Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analyzing array data using supervised methods.

Markus Ringnér1, Carsten Peterson, Javed Khan

  • 1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Building 50, Room 5142,50 South Drive MSC 8000, Bethesda, MD 20892, USA. mringner@nhgri.nih.gov.

Pharmacogenomics
|June 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026
Same author

Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.

JCO precision oncology·2026
Same author

An insight into the molecular identity and distribution of <i>Microhyla taraiensis</i> (Anura, Microhylidae) in Khyber Pakhtunkhwa, Pakistan.

ZooKeys·2026
Same author

Enhancing Compliance: Tailored Training on IATA Regulations for Shipping Infectious Substances and Biological Specimens for Targeted Cohorts in Pakistan.

Applied biosafety : journal of the American Biological Safety Association·2026
Same author

MicroRNA-21 in Cancer and Fibrosis: Molecular Mechanisms and Therapeutic Progress.

Anti-cancer agents in medicinal chemistry·2026
Same author

Nanomedicine for Alzheimer's Disease: Diagnostic and Therapeutic Progress.

MicroRNA (Shariqah, United Arab Emirates)·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Pharmacogenomics uses genomic data for drug discovery and understanding drug actions. Analyzing this complex data requires computational methods, with supervised learning showing promise for gene and sample characterization.

Area of Science:

  • Genomics
  • Pharmacology
  • Bioinformatics

Background:

  • Pharmacogenomics integrates genomic technologies into drug discovery and development.
  • Understanding drug mechanisms at cellular and organismal levels is crucial.
  • DNA microarrays are key tools for genome-wide gene expression analysis in pharmacogenomics.

Purpose of the Study:

  • To review computational methods for analyzing large-scale genomic data in pharmacogenomics.
  • To highlight the importance of supervised methods in characterizing genes and samples.
  • To familiarize researchers with the scope and limitations of various analysis techniques.

Main Methods:

  • Review of computational and supervised learning methods for analyzing gene expression data.
  • Focus on methods applicable to pharmacogenomic research, including target identification and toxicological studies.

Related Experiment Videos

  • Discussion of data management and analysis strategies for genome-wide investigations.

    • Main Results:

    • Genome-wide studies generate substantial data, necessitating advanced computational analysis.
    • Supervised methods, utilizing additional information alongside gene expression data, are increasingly used.
    • The selection of analysis methods significantly impacts the interpretation of pharmacogenomic results.

    Conclusions:

    • Effective computational methods are essential for managing and interpreting pharmacogenomic data.
    • Familiarity with different analytical approaches, their strengths, and weaknesses is critical for successful pharmacogenomic research.
    • Supervised learning offers valuable tools for gene and sample characterization in drug development.